Larry Anderson

Larry Anderson, M.D., Ph.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in Hematology/Oncology. His academic affiliation includes membership in the Division of Hematology and Oncology. He holds certifications from the American Board of Internal Medicine in Medical Oncology and is a Diplomate of both the ABIM and its Medical Oncology subspecialty board. Dr. Anderson's research focuses on cancer immunology, immunotherapy, multiple myeloma, and stem cell transplantation, with over 30 peer-reviewed publications and presentations internationally.

**Education:**

• B.S. in Biomedical Sciences (magna cum laude), Texas A&M University
• M.D. and Ph.D. in Immunology, University of Texas-Houston Health Science Center
• Internal Medicine Residency, Mayo Clinic, Rochester, MN
• Medical Oncology Fellowship, University of Washington Medical Center/Fred Hutchinson Cancer Research Center

**Research Interests:**

Dr. Anderson investigates immunotherapeutic strategies for hematologic malignancies, including CAR-T cell therapies, BCMA targeting, and bone marrow transplantation for plasma cell disorders. His work bridges laboratory discoveries with clinical applications, emphasizing translational research in multiple myeloma and Waldenström macroglobulinemia.

**Awards:**

• Named 'Super Doctor' by Texas Monthly

**Clinical & Academic Contributions:**

He leads studies on novel combination therapies (e.g., daratumumab/lenalidomide/bortezomib) and evaluates real-world outcomes of CAR-T cell therapies like idecabtagene vicleucel. His work addresses toxicity management, patient subgroups (e.g., elderly, frail), and biomarkers predicting therapy response.

**Labs & Collaborations:**

Active in the UT Southwestern Hematology/Oncology division, collaborating with institutions like Fred Hutchinson Cancer Research Center and Mayo Clinic on clinical trials and translational studies.